Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations
Clinical trial NCT07338942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07338942
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2027-11-20
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.